Changes in the financing landscape for glioma drug development & ONC201
Time: 9:00 am
day: Conference Day Two
Details:
- Historical challenges of glioma drug development and funding constraints
- Improving landscape of investing in glioma drug development
- Applying lessons learned to ONC201 (dordaviprone) development
